Table 4.
Correlation between the expression of EPCAM and prognosis
| Low expression of EPCAM | High expression of EPCAM | χ2 | P | |
|---|---|---|---|---|
| Intestinal-type |
6.9.7% |
34.2% |
29.15 |
0.001 |
| Diffuse-type |
12.9% |
8.6% |
37.11 |
0.001 |
| PN0 |
78.2% |
40.7% |
35.77 |
0.001 |
| PN1 |
33.1% |
15.0% |
37.72 |
0.001 |
| PN2 |
19.0% |
8.6% |
17.31 |
0.001 |
| PN3 |
4.3% |
0% |
3.21 |
0.073 |
| Stage I |
89.1% |
62.5% |
4.89 |
0.027 |
| Stage II |
60.3% |
47.4% |
7.648 |
0.006 |
| Stage III |
22.2% |
12.9% |
35.58 |
0.0001 |
| Stage IV | 0% | 2.3% | 0.268 | 0.605 |